Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials

Sandra P. D'Angelo, Michelle R. Mahoney, Brian A. Van Tine, James Atkins, Mohammed M. Milhem, Balkrishna N. Jahagirdar, Cristina R. Antonescu, Elise Horvath, William D. Tap, Gary K. Schwartz, Howard Streicher

Research output: Contribution to journal › Article › peer-review

522 Scopus citations

Fingerprint

Dive into the research topics of 'Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science